Eric Bednarski

Director/Board Member at MDXHEALTH SA

54 year

Health Technology

Finance

Consumer Services

Profile

Eric Bednarski was the founder of Ampla Pharmaceuticals, Inc. (2006) and Prexa Pharmaceuticals, Inc. (2006) with the title of Director.
Current jobs include Chairman at Tarsa Therapeutics, Inc., Director at Biotheranostics, Inc., Non-Independent Non-Executive Director at MDxHealth SA (2020), Director at Neurolens, Inc., Partner at MVM Partners LLC (2008), and Partner at MVM Partners LLP (2008).
Former jobs include Director at SOLX, Inc., Non-Executive Director at Nxera Pharma UK Ltd., Director-Corporate Finance Group at Silicon Valley Bank, Director at AccuVein, Inc., Independent Director at OptiNose, Inc. (2021-2025), Principal at Advent International LP (2001-2007), Principal at SVB Asset Management, Principal at DuPont Merck Pharmaceutical Co., and Partner at Synthesis Capital.
Education includes an undergraduate degree from Brown University and a doctorate from the University of California.

Eric Bednarski active positions

Companies	Position	Start
MDXHEALTH SA	Director/Board Member	30/07/2020
Neurolens, Inc. Neurolens, Inc. Electronic ComponentsElectronic Technology Develops prescription lenses	Director/Board Member	-
MVM Partners LLC MVM Partners LLC Investment ManagersFinance Functions as an alternative investment manager	Private Equity Investor	01/01/2008
Biotheranostics, Inc. Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients	Director/Board Member	-
Tarsa Therapeutics, Inc. Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral treatment for post-menopausal osteoporosis	Chairman	21/10/2009
MVM Partners LLP MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm targets companies operating in the fields of healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million.	Private Equity Investor	01/01/2008

All active positions of Eric Bednarski

Former positions of Eric Bednarski

Companies	Position	End
OPTINOSEPAR	Director/Board Member	21/05/2025
Advent International LP Advent International LP Investment ManagersFinance Advent invests in companies located across the globe. The firm targets companies operating in the fields of business & financial services, healthcare, industrial and technology services. It provides financing for leveraged buyout, recapitalizations, growth and public to private transactions. It also acquires majority and minority ownership.	Private Equity Analyst	01/05/2007
SVB Asset Management SVB Asset Management Investment ManagersFinance SVB Asset Management utilizes both top-down and bottom-up portfolio management approaches. Their investment process includes quantitative and qualitative analysis using its own and third-party proprietary systems and methods. The firm offers three primary investment strategies: Corporate Cash Management Strategy, Total Return Strategy and ESG Strategy.	Corporate Officer/Principal	31/12/2000
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░	-
░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Eric Bednarski's experience

Training of Eric Bednarski

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eric Bednarski's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	19
Advent International LP Advent International LP Investment ManagersFinance Advent invests in companies located across the globe. The firm targets companies operating in the fields of business & financial services, healthcare, industrial and technology services. It provides financing for leveraged buyout, recapitalizations, growth and public to private transactions. It also acquires majority and minority ownership.	Finance
Biotheranostics, Inc. Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients	Health Services
MDxHealth SA MDxHealth SA Medical SpecialtiesHealth Technology Develops and commercializes epigenetic tests & services for cancer assessment	Health Technology
Ampla Pharmaceuticals, Inc. Ampla Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the drug discovery of novel oral small molecule drugs for treatment of diabetes and metabolism disorders	Health Technology
Prexa Pharmaceuticals, Inc. Prexa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral small molecule monoamine reuptake inhibitors	Health Technology
OptiNose, Inc. OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases	Health Technology
Brown University Brown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SVB Asset Management SVB Asset Management Investment ManagersFinance SVB Asset Management utilizes both top-down and bottom-up portfolio management approaches. Their investment process includes quantitative and qualitative analysis using its own and third-party proprietary systems and methods. The firm offers three primary investment strategies: Corporate Cash Management Strategy, Total Return Strategy and ESG Strategy.	Finance
MVM Partners LLP MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm targets companies operating in the fields of healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million.	Finance
DuPont Merck Pharmaceutical Co. DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs	Health Technology
SOLX, Inc. SOLX, Inc. Medical SpecialtiesHealth Technology Specializes in management and surgical treatment of glaucoma	Health Technology
Nxera Pharma UK Ltd. Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors	Health Technology
Silicon Valley Bank Silicon Valley Bank Regional BanksFinance Provides commercial banking services	Finance
Tarsa Therapeutics, Inc. Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral treatment for post-menopausal osteoporosis	Health Technology
AccuVein, Inc. AccuVein, Inc. Medical SpecialtiesHealth Technology Develops products that aid in the visualization of peripheral vasculature	Health Technology
Synthesis Capital Synthesis Capital Investment ManagersFinance Synthesis Capital invests in US and European-based companies. The firm targets companies operating in the fields of bio-pharmaceutical and medical technology sectors. It provides financing for seed, early and late stage capital requirements.	Finance
University of California University of California Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
MVM Partners LLC MVM Partners LLC Investment ManagersFinance Functions as an alternative investment manager	Finance
Neurolens, Inc. Neurolens, Inc. Electronic ComponentsElectronic Technology Develops prescription lenses	Electronic Technology